Piper Jaffray Raises Price Target on Abiomed (ABMD) Following 1Q16

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. USO
6. TSLA
7. AMD
8. META
9. AMC
10. COHR

Go back to Piper Jaffray Raises Price Target on Abiomed (ABMD) Following 1Q16

Abiomed to Hold Investor Day in Boston on August 11

August 5, 2015 8:01 AM EDT

DANVERS, Mass., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD) announced today that the Company will webcast presentations at its Investor Day held in Boston, MA on Tuesday, August 11, 2015, from 9:00 a.m. to approximately 12:00 p.m. EDT. 

Abiomed will host a physician panel of experts, present our corporate strategy and 5 year revenue projection, describe a new patient population of interest and unveil a future product for heart failure.

... More

Abiomed Announces Q1 FY 2016 Revenue of $73.4 Million, Up 50% Over Prior Year

August 4, 2015 7:00 AM EDT

DANVERS, Mass., Aug. 04, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2016 revenue of $73.4 million, an increase of 50% compared to revenue of $48.8 million for the same period of fiscal 2015. First quarter fiscal 2016 GAAP net income was $8.9 million or $0.20 per diluted share, compared to GAAP net loss of $1.7 million or a loss of $0.04 per diluted share for... More